The Korea Herald

피터빈트

LegoChem Bio receives approval for superbacterial antibiotic test

By 윤정현

Published : Aug. 24, 2016 - 17:35

    • Link copied

[DISCLOSURE] LegoChem Biosciences (141080) announced on Aug. 24 that it has obtained approval from the Ministry of Food and Drug Safety for a phase I clinical study of LCB01-0371, an injectable antibiotic that targets superbacteria.
The company added that oral medication is currently undergoing a phase II clinical study and will be later developed in the form of injection.

By Yun Jeong-hyeon (clareyun@heraldcorp.com)